Weckhuysen, Sarah
University of Antwerp · Antwerp University Hospital · VIB-UAntwerp Center for Molecular Neurology
15 papers on CoChatORCID 0000-0003-2878-1147
Most cited papers
- Verified
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain
Epilepsy research and treatmentIon channel regulation and function
Cited by 600
- Verified
KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R. F., Deprez, L., Smets, K., Hristova, D., Yordanova, I., et al. (2012) · Annals of Neurology
Epilepsy research and treatmentIon channel regulation and function
Cited by 514
- Verified
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 439
- Verified
Dissecting the genetic basis of focal cortical dysplasia: a large cohort study
Baldassari, S., Ribierre, T., Marsan, E., Adle-Biassette, H., Ferrand-Sorbets, S., Bulteau, C., Dorison, N., Fohlen, M., Polivka, M., Weckhuysen, S., et al. (2019) · Acta Neuropathologica
Epilepsy research and treatmentTuberous Sclerosis Complex Research
Cited by 356
- Verified
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures
Carvill, G. L., McMahon, J. M., Schneider, A., Zemel, M., Myers, C. T., Saykally, J., Nguyen, J., Robbiano, A., Zara, F., Specchio, N., et al. (2015) · The American Journal of Human Genetics
Epilepsy research and treatmentNeuroscience and Neuropharmacology Research
Cited by 227
- Verified
De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome
Suls, A., Jaehn, J. A., Kecskés, A., Weber, Y., Weckhuysen, S., Craiu, D. C., Siekierska, A., Djémié, T., Afrikanova, T., Gormley, P., et al. (2013) · The American Journal of Human Genetics
Epilepsy research and treatmentIon channel regulation and function
Cited by 219
- Verified
Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy
Lemke, J. R., Geider, K., Helbig, K. L., Heyne, H. O., Schütz, H., Hentschel, J., Courage, C., Depienne, C., Nava, C., Heron, D., et al. (2016) · Neurology
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 200
- Verified
Assessing the landscape of STXBP1 -related disorders in 534 individuals
Xian, J., Parthasarathy, S., Ruggiero, S. M., Balagura, G., Fitch, E., Helbig, K., Gan, J., Ganesan, S., Kaufman, M. C., Ellis, C. A., et al. (2022) · Brain
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 130
- Verified
CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures
Thomas, R. H., Zhang, L. M., Carvill, G. L., Archer, J. S., Heavin, S. B., Mandelstam, S. A., Craiu, D., Berkovic, S. F., Gill, D. S., Mefford, H. C., et al. (2015) · Neurology
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 100
- Verified
Widespread genomic influences on phenotype in Dravet syndrome, a ‘monogenic’ condition
Martins Custodio, H., Clayton, L. M., Bellampalli, R., Pagni, S., Silvennoinen, K., Caswell, R., Genomics England Research Consortium, Ambrose, J. C., Arumugam, P., Bevers, R., et al. (2023) · Brain
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 62
- Verified
Simultaneous impairment of neuronal and metabolic function of mutated gephyrin in a patient with epileptic encephalopathy
Dejanovic, B., Djémié, T., Grünewald, N., Suls, A., Kress, V., Hetsch, F., Craiu, D., Zemel, M., Gormley, P., Lal, D., et al. (2015) · EMBO Molecular Medicine
Neuroscience and Neuropharmacology ResearchEpilepsy research and treatment
Cited by 49
- Verified
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants
Mohammadi, N. A., Ahring, P. K., Yu Liao, V. W., Chua, H. C., Ortiz de la Rosa, S., Johannesen, K. M., Michaeli-Yossef, Y., Vincent-Devulder, A., Meridda, C., Bruel, A.-L., et al. (2024) · eBioMedicine
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 27
- Verified
Head stereotypies in STXBP 1 encephalopathy
Kim, Y. O., Korff, C. M., Villaluz, M. M. G., Suls, A., Weckhuysen, S., De Jonghe, P., & Scheffer, I. E. (2013) · Developmental Medicine & Child Neurology
Genetics and Neurodevelopmental DisordersEpilepsy research and treatment
Cited by 25
- Verified
The fast‐dissociating D 2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment
Carotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology
Ion channel regulation and functionEpilepsy research and treatment
Cited by 10
- Verified
Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy
Macha, A., Liebsch, F., Fricke, S., Hetsch, F., Neuser, F., Johannes, L., Kress, V., Djémié, T., Santamaria-Araujo, J. A., Vilain, C., et al. (2022) · Human Molecular Genetics
Epilepsy research and treatmentNeuroscience and Neuropharmacology Research
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free